6505--Venlafaxine Tablets

The Department of Veterans Affairs National Acquisition Center is seeking to procure Venlafaxine HCL tablets through Solicitation Number 36E79725R0054. The procurement covers five different tablet strengths (25mg, 37.5mg, 50mg, 75mg, and 100mg), each packaged in 90-tablet bottles with safety-cap packaging and bar coding requirements. The contract will serve multiple federal agencies including the VA, Department of Defense, Indian Health Service, Bureau of Prisons, and Federal Health Care Centers. This will be structured as a firm fixed-price requirements contract spanning a base year plus four one-year option periods. Offerors must submit pricing for all line items and strengths, including a mandatory 0.5% Cost Recovery Fee, and must comply with Drug Supply Chain Security Act regulations. Proposals are due by August 26, 2025, at 2:30 PM Central Time.

This solicitation is set aside for small businesses under the NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with a size standard of 1,300 employees. The estimated annual usage varies significantly across the different tablet strengths, ranging from 4,259 bottles for some strengths to 52,995 bottles for others. Distribution will be handled through Pharmaceutical Prime Vendor contractors, specifically mentioning McKesson Corporation as the distribution partner. The contract structure allows for a potential five-year total performance period when including all option years. No specific contract value range was disclosed in the available documentation, though the substantial quantities and multi-year structure suggest a significant procurement opportunity for qualified pharmaceutical manufacturers.